Clinical Trials Logo

Threatened Miscarriage clinical trials

View clinical trials related to Threatened Miscarriage.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT02690129 Recruiting - Clinical trials for Threatened Miscarriage

Vaginal Progesterone for Treatment of Threatened Miscarriage

VPM
Start date: February 2016
Phase: N/A
Study type: Interventional

The purpose of the study is to assess the efficacy of vaginal micronized progesterone in the treatment of threatened miscarriage. All eligible pregnant women will be randomized to either receive vaginal progesterone or no treatment.Evaluation will be two weeks after intervention, then every 4 weeks up to 28 weeks gestation or termination of pregnancy.

NCT ID: NCT02633878 Recruiting - Clinical trials for Threatened Miscarriage

Chinese Herbal Medicine and Micronized Progesterone for Live Births in Threatened Miscarriage

Start date: September 1, 2017
Phase: Phase 2
Study type: Interventional

Threatened miscarriage is manifested by vaginal bleeding, with or without abdominal pain, while the cervix is closed and the fetus is viable and inside the uterine cavity. Threatened miscarriage is a common complication of pregnancy occurring in 20% of all clinically recognized pregnancies and about half of these will eventually result in pregnancy loss. The goal of this double-bind, randomized and double dummy controlled trial is to determine which of the two oral medications, CHM or micronized progesterone, and will mostly likely result in live birth in women with threatened miscarriage. We will evaluate the efficacy and safety of CHM and micronized progesterone for treating threatened miscarriage in this trial. Our primary outcome of this trial is a live birth. We hypothesize that: 1. treatment with CHM plus micronized progesterone placebo or micronized progesterone plus CHM placebo or CHM plus Micronized progesterone is more likely to result in live birth than the control arm which will be CHM placebo plus micronized progesterone placebo; 2. CHM plus micronized progesterone placebo and micronized progesterone plus CHM placebo will have similar treatment effects.